logo
Melting of billions of sea stars linked to bacteria that's also deadly to humans

Melting of billions of sea stars linked to bacteria that's also deadly to humans

Yahooa day ago
Researchers have unmasked the deadly bacteria responsible for causing sea stars to melt away, killing billions over the past decade and upending marine ecological habitats.
Sea Star Wasting Disease, or SSWD, is considered the largest marine epidemic ever documented in the wild and killed billions of sea stars from Alaska to Mexico, according to the Tula Foundation, which is among the organizations investigating this deadly disease. SSWD has wiped out 90% of sunflower sea stars along the west coast of North America.
Record-breaking Mega Coral Visible From Space Is Possibly 300 Years Old
The symptoms of the washing disease start with lesions on the outside of a sea star and eventually turns deadly as its tissue "melts." The whole process takes about two weeks, causing sea stars to become completely disfigured, often losing their arms in the process.
The cause of this disease has remained elusive for the past decade, until now.
An international team of researchers from the Hakai Institute, the University of British Columbia (UBC) and the University of Washington pinpointed a strain of bacterium, Vibrio pectenicida, as the culprit behind the death of billions of sea stars.
Vibrio is a genus of bacteria deadly to coral and shellfish. Vibrio cholerae is the pathogen that causes cholera in humans.
It took years of honing in on different pathogens before the team finally found a match.
"When we looked at the coelomic fluid between exposed and healthy sea stars, there was basically one thing different: Vibrio," said senior study author Alyssa Gehman, a marine disease ecologist with Hakai Institute and UBC. "We all had chills. We thought, That's it. We have it. That's what causes wasting."
Researchers Use Seaweed To Cut Concrete's Carbon Footprint
Their findings were published this week in the journal Nature Ecology & Evolution, and came after four years of research in partnership with The Nature Conservancy, the Tula Foundation, the U.S. Geological Survey's Western Fisheries Research Center and the Washington Department of Fish and Wildlife.
Study author Melanie Prentice, an evolutionary ecologist at the Hakai Institute and UBC, said the massive loss of sunflower sea stars has caused widespread changes across coastal ecosystems.
"When we lose billions of sea stars, that really shifts the ecological dynamics," Prentice said in a statement. "In the absence of sunflower stars, sea urchin populations increase, which means the loss of kelp forests, and that has broad implications for all the other marine species and humans that rely on them. So losing a sea star goes far beyond the loss of that single species."
The research team said identifying the cause of the wasting disease is the first crucial step toward recovery.
Gehman said scientists can now look at additional factors of the disease, including ocean temperature. Vibrio is known to multiply in warm water.Original article source: Melting of billions of sea stars linked to bacteria that's also deadly to humans
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dairy Companies Slash Added Sugars by Nearly 60% in School Milk as New School Year Begins
Dairy Companies Slash Added Sugars by Nearly 60% in School Milk as New School Year Begins

Associated Press

time31 minutes ago

  • Associated Press

Dairy Companies Slash Added Sugars by Nearly 60% in School Milk as New School Year Begins

WASHINGTON, D.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The nation's school milk processors have reduced added sugars by nearly 60% in flavored milk products sold at schools as a result of a voluntary, industry-led effort. The International Dairy Foods Association (IDFA) today announced the results of the Healthy School Milk Commitment launched in April 2023 by 37 school milk processors representing approximately 95% of the school milk volume in the United States. The Commitment calls on dairy companies to provide healthy, nutritious school milk options with fewer calories and no more than 10 grams of added sugar per 8-ounce serving by the 2025-2026 school year. The latest survey by IDFA shows the current level of added sugar in flavored milk is 7.2 grams per serving on average, demonstrating that all companies have met or exceeded the pledge. Added sugar levels in flavored milk products sold at schools have plummeted by 57% since 2006 thanks to the voluntary, proactive efforts of America's school milk processors. Calories associated with flavored milk have also declined during that same period, from 166 to 123 calories per 8-ounce serving. The industry's efforts are outpacing a U.S. government threshold set in 2024 by a wide margin. IDFA announced the Healthy School Milk Commitment in 2023, creating the first voluntary, proactive industry commitment related to foods sold at school. One year later, the U.S. Department of Agriculture (USDA) updated its school meal standards to reflect the 10 grams or less pledge of the IDFA Commitment. Now, school milk processors have surpassed their own pledge ahead of government standards taking effect. As the 2025-2026 school year begins, the average flavored milk product is packed with milk's 13 essential nutrients and contains just 7.2 grams of added sugar per serving. Since 2023, dairy companies have reformulated 24 individual products. Flavored milk provides students with one of the most complete nutrient packages while contributing less than 4% of added sugars in the diets of children 2-18 years. In fact, the total sugar in flavored milk sold in schools is below total sugar in 100% fruit juice sold in schools such as apple and orange juice, with more nutrients, too. 'By slashing added sugars in school milk, America's dairy companies are fulfilling their pledge to America's parents and children to offer wholesome, nutritious milk options with fewer calories and the same essential nutrients,' said Michael Dykes, D.V.M., president and CEO of IDFA. 'Thirty-seven milk processors have worked for more than two years to reformulate their products to reduce added sugars, lower calories, remove artificial colors, and offer new lactose-free options, all while maintaining milk's 13 essential nutrients that children need for healthy growth and development. School milk is the leading source of calcium, vitamin D, and potassium for American children. IDFA and our nation's dairy farmers and school milk processors will continue to step up in a big way to provide wholesome and healthy milk options to children year around.' 'School nutrition professionals are proud to support our students' health and achievement by offering milk as a part of well-balanced, nutritious school meals,' said School Nutrition Association President Stephanie Dillard, MS, SNS. 'America's milk processors are a critical partner in our members' ongoing work to improve the nutrition and quality of school meals while meeting updated school nutrition standards. This achievement is another reason why parents should feel confident encouraging their students to enjoy healthy school meals as they head back to school.' 'The Urban School Food Alliance applauds the work of the IDFA and milk processors for continuing to put student health and well-being first!' said Dr. Katie Wilson, SNS, executive director of the Urban School Food Alliance. 'By voluntarily reducing sugar in flavored milk, processors have made it easier for us to Keep Milk on the School Lunch Tray while educating students and parents on how fresh milk is an essential part of a healthy diet. These types of partnerships continue to move the quality of school meals forward and are beneficial to all, particularly the students we serve nationwide.' USDA's school meal programs including lunch and breakfast serve 30 million children every day. The IDFA Healthy School Milk Commitment was expanded in late 2023 to include USDA's Summer Food Service Program, a program that provides healthy meals and snacks to up to 3.2 million low-income children and teens during the summer months when schools are out of session. Earlier this year, dairy companies also committed to remove all certified artificial colors in dairy products in school meals—including milk products—by 2026, further demonstrating the dairy industry's commitment to child nutrition. The most recent Dietary Guidelines for Americans report is clear: children are not receiving enough essential nutrients for growth, development, healthy immune function, and overall wellness. Healthy milk and dairy options in school meals—including lactose-free and reduced-lactose options—are the most important opportunity of the day for children to get the critical nutrients they need. More than two-thirds of milk consumed by children in school today is flavored, such as chocolate and strawberry milk. Therefore, the reductions in sugar and calories achieved by IDFA's Healthy School Milk Commitment are critical to improving child nutrition. School milk is the number one source of high-quality protein, vitamin D, calcium, and potassium for children ages 2-18. Nutrition science is clear that consumption of cow's milk provides children with better bone health, a lower risk for type 2 diabetes, and a lower risk for cardiovascular disease. Children who drink flavored milk consume more milk and therefore have significantly higher intakes of vitamin D, calcium, potassium, and other nutrients. The IDFA Healthy School Milk Commitment joins a string of proactive, voluntary efforts by U.S. dairy, including the IDFA Healthy Dairy in Schools Commitment announced in April 2025—which pledged to remove certified artificial colors in milk, cheese, and yogurt products sold to schools by July 2026—and the IDFA Ice Cream Commitment announced in July 2025—which pledges to eliminate the use of certified artificial colors in ice cream products made with real milk and sold at food retail by Dec. 31, 2027. The dairy industry is also working with schools and nutrition professionals to educate school staff and students about the benefits of healthy dairy options in diets to promote positive health outcomes. For more information about the Healthy School Milk Commitment, visit # # # The International Dairy Foods Association (IDFA), Washington, D.C., represents the nation's dairy manufacturing and marketing industry, which supports more than 3 million jobs that generate $198 billion in wages and $779 billion in overall economic impact. IDFA's diverse membership ranges from multinational organizations to single-plant companies, from dairy companies and cooperatives to food retailers and suppliers, all on the cutting edge of innovation and sustainable business practices. Together, they represent most of the milk, cheese, ice cream, yogurt and cultured products, and dairy ingredients produced and marketed in the United States and sold throughout the world. Delicious, safe and nutritious, dairy foods offer unparalleled health and consumer benefits to people of all ages. IDFA Press International Dairy Foods Association [email protected]

On Vaccines, Kennedy Has Broken Sharply With the Mainstream
On Vaccines, Kennedy Has Broken Sharply With the Mainstream

New York Times

timean hour ago

  • New York Times

On Vaccines, Kennedy Has Broken Sharply With the Mainstream

Even before Robert F. Kennedy Jr. took office in February as secretary of the Department of Health and Human Services, some public health experts worried he might use his influence to carry out an anti-vaccine agenda he'd spent decades promoting. In the worst-case scenario, they said, he might dismiss experts on whom the government relies to make sound decisions about immunizations and enact policies restricting access. He might cancel important research that would be needed in a future pandemic. In less than six months, Mr. Kennedy has done all that and more. The health secretary has expressed doubts about childhood vaccines, including those against polio and measles, that have been the mainstay of childhood immunizations for decades. He has described the Covid shot as 'the deadliest vaccine ever made.' Under his leadership, the Food and Drug Administration restricted access to the Covid vaccines for healthy pregnant women and children. And on Tuesday, he canceled nearly $500 million of grants and contracts for work on mRNA vaccines, the technology that helped turn the tide against the coronavirus. Mr. Kennedy explained his decision in a video on social media, claiming falsely that mRNA vaccines offer no protection against respiratory viruses and can prolong pandemics. Most scientists were aghast. His assault on mRNA vaccines, and in particular the Covid vaccines developed in the first Trump administration, may have even riled the president. Want all of The Times? Subscribe.

Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag
Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag

Forbes

timean hour ago

  • Forbes

Coverage Of Weight Loss Drugs By Medicaid Plans Continues To Lag

California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are considering similar cuts. States are struggling to close gaps in budgets. Enactment of The Big Beautiful Bill will likely add pressure on budget finances. It's hard to envision a scenario in which state Medicaid agencies expand coverage of weight loss treatments in the short term. About 40% of adult Americans are considered obese. Rates of obesity have been steadily on the rise since 1980. The Harvard T.H. Chan School of Public Health reminds us that obesity increases the risk of developing conditions such as diabetes, heart disease, osteoarthritis and several cancers. Medications known as glucagon-like peptide-1 agonists, or GLP-1s, have become very popular as weight loss agents. Taken in accordance with the instructions on the label and an appropriate diet and exercise regimen, GLP-1s are effective at lowering a person's weight. However, payers in both the commercial and public sectors often balk at coverage. Commercial insurance coverage is improving but still isn't universal by any means, whether in the employer-sponsored segment or individual market. In the federal insurance program for the elderly and some disabled persons, Medicare, coverage of GLP-1s for weight loss alone is prohibited, though obese patients can get the semaglutide-based product, Wegovy, covered for heart disease. Medicaid, a federal-state partnership that provides health coverage for low-resourced people, generally doesn't reimburse GLP-1s for obesity. Only 14 states cover obesity medications in their state Medicaid plans. And like California, other states have proposed cutting coverage for obesity medications or have already done so, whether in the Medicaid program itself or state employee plans. For example, North Carolina and West Virginia have recently eliminated coverage of GLP-1s for weight loss for state employees due to cost concerns. With significant Medicaid cuts in federal budget outlays as a result of passage of The Big Beautiful Bill, it is likely more states will follow suit. The law severely restricts how states pay for their share of Medicaid costs. To illustrate, states have long used healthcare provider taxes and certain special payment arrangements to fund their portion of the program. Yet the new legislation limits these financing tools, effectively shifting hundreds of billions in costs to state budgets. States that do opt to cover various weight loss treatments, including medications, nutrition programs and bariatric surgery, almost invariably deploy restrictive eligibility requirements around things like body mass indices and the presence of co-morbidities, along with the use of prior authorization and step edits. This means, for instance, that individuals wanting to access treatments must attest to 'increased exercise activity' and submit documentation proving that they've tried and failed to lose weight after receiving nutrition counseling and going on a strict, low-calorie diet. In light of budget constraints, steep cuts to a wide range of Medicaid benefits are probable in the short term. This may come in the form of even more severe limits on coverage of medicines and other healthcare technologies, including obesity treatments. It's possible that through a voluntary demonstration project that the Centers for Medicare and Medicaid Services announced last month, some state Medicaid agencies could soon elect to cover these drugs for 'weight management.' But the plan has not been finalized. Nor have any details been divulged besides the fact that it would commence in April of next year for Medicaid. Without information on how state programs would be incentivized to sign up, it's unclear who would be interested. The perennial issue for all types of payers is money. Once these therapeutics are covered by insurance, they tend to blow up budgets. Many payers in the commercial sector cite serious budgetary concerns. A survey released this spring of employer-based plans shows that GLP-1 drugs used for obesity account for an average of 10.5% of total annual claims. And if Medicare were to lift its prohibition on coverage, it would cost the program a cumulative $35 billion from 2026-2034. While the estimates included possible savings from improved health, these were not nearly sufficient to offset the costs of the medications. Such projected expenses haven't been calculated specifically for Medicaid. But the churn or enrollee turnover is so high in Medicaid that any longer-term, downstream cost savings would be very hard to come by, further exacerbating the budgetary problem. While cost is a primary consideration for payers, lack of persistence on GLP-1s is another reason for hesitance to reimburse weight loss drugs. Patients who are treated with GLP-1s tend to discontinue at a relatively high rate. One study cited by federal government policymakers found that approximately 53% of patients with overweight or obesity taking semaglutide-based products didn't persist on treatment past two months. Starting and stopping on these medicines so soon yields little or no benefit to patients and only adds costs for payers. It's possible that employers, commercial insurers and payers in the public sector—including Medicaid—decide to eventually revisit their coverage decisions if net prices of GLP-1s decrease sufficiently, combined with more data showing the benefits of weight loss drugs when taken consistently and persistently in conjunction with an appropriate dietary and exercise regimen. Until that time, however, coverage will continue to be a major hurdle.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store